Biohaven Pharma (BHVN) Tops Q2 EPS by 31c
Biohaven Pharma (NYSE: BHVN) reported Q2 EPS of ($1.63), $0.31 better than the analyst estimate of ($1.94).
For earnings history and earnings-related data on Biohaven Pharma (BHVN) click here.
Biohaven Pharma (NYSE: BHVN) reported Q2 EPS of ($1.63), $0.31 better than the analyst estimate of ($1.94).
For earnings history and earnings-related data on Biohaven Pharma (BHVN) click here.